Role of Vif in stability of the human immunodeficiency virus type 1 core

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11055-11066

  Ohagen A ^a   Gabuzda, D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIF PROTEIN; VIRUS DNA;

ARTICLE; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; REVERSE TRANSCRIPTION; VIRION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS NUCLEOCAPSID;

CELLS, CULTURED; DETERGENTS; GENE PRODUCTS, VIF; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON; SODIUM CHLORIDE; VIRION; VIRUS ASSEMBLY;

EID: 0034467080     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11055-11066.2000     Document Type: Article

References (70)

1. A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly
2. gag
3. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A
4. Two species of full-length cDNA are synthesized in high yield by melittin-treated avian retrovirus particles
5. - mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
6. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: Characterization of the endogenous reverse transcriptase reaction
7. Gag precursor
8. - human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
9. Cyclosporin A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A
10. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
11. Characterization of human immunodeficiency virus type 1 Vif particle incorporation
12. Vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages producing attenuated progeny virus
13. - human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps
14. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2′,3′-dideoxynucleoside 5′-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio) thymine derivates
15. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
16. Functional domains of the capsid protein of human immunodeficiency virus type 1
17. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription
18. Targeting of HIV- and SIV infected cells by CD4-chemokine receptor pseudotypes
19. Cell-free transmission of Vif mutants of HIV-1
20. The sor gene of HIV-1 is required for efficient virus transmission in vitro
21. 2-terminal capsid domain: Structure determinants for proper core assembly and subsequent steps of early replication
22. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
23. Specific incorporation of cyclophilin A into HIV-1 virions
24. + T lymphocytes
25. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid
26. Role of Vif in human immunodeficiency type 1 reverse transcription
27. Role of Vif during packing of the core of HIV-1
28. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins
29. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein
30. Vpx association with mature core structures of HIV-2
31. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle
32. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro
33. Association of Nef with the human immunodeficiency virus type 1 core
34. Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: Pore formation by melittin
35. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus
36. + T cells
37. A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system
38. Localization of viral protein X in simian immunodeficiency virus macaque strain and analysis of its packaging requirements
39. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
40. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
41. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis
42. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in "nonpermissive" T lymphoid cells stably infected with selectable HIV-1
43. Restricted antigenic variability of the epitope recognized by the neutralizing antibody 2F5
44. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
45. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle
46. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus
47. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
48. Aberrant Gag protein composition of human immunodeficiency virus type 1 vif mutants produced in lymphocytes
49. Gag polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes
50. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells
51. Evidence for a newly discovered cellular anti-HIV-1 phenotype
52. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
53. Virion incorporation of human immunodeficiency virus type 1 Vif is determined by intracellular expression level and may not be necessary for function
54. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission
55. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions
56. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with Vif-negative human immunodeficiency virus type 1
57. The HIV 'A' (sor) gene product is essential for virus infectivity
58. Functional association of cyclophilin A with HIV-1 virions
59. Structural biology of HIV
60. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
61. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1
62. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites
63. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlate with infectivity of human immunodeficiency virus type 1
64. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels
65. Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction
66. Vpx of simian immunodeficiency virus is located primarily outside the virus core in mature virions
67. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
68. Endogenous reverse transcription of human immunodeficiency type 1 in physiological microenvironments: An important stage for viral infection of nondividing cells
69. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process